Search research articles
Contact Us
Filters
Showing results (21-30 of 119) with videos related to
Page
of 12
Sort By:
BMJ Open
|
July 25, 2018
Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States
Xiaomei Ma, David P Steensma, Bart L Scott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2017
Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents
Moreno Festuccia, Kelsey Baker, Theodore A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 30, 2016
Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial
Janghee Woo, H Joachim Deeg, Barry Storer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 17, 2015
The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis
Bethany T Samuelson, Sara K Vesely, Chatree Chai-Adisaksopha, et al.
British Journal of Haematology
|
March 25, 2010
Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study
Bart L Scott, Aravind Ramakrishnan, Mark Fosdal, et al.
Blood
|
July 9, 2008
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome
Bart L Scott, Denise A Wells, Michael R Loken, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 4, 2019
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab
Jason P Cooper, Rafic J Farah, Philip A Stevenson, et al.
British Journal of Haematology
|
January 13, 2010
Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept
Bart L Scott, Aravind Ramakrishnan, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 24, 2007
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia
Bart L Scott, Barry E Storer, Joanne E Greene, et al.
Bone Marrow Transplantation
|
September 2, 2018
Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD
Armin Rashidi, Ryan Shanley, Claudio Anasetti, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 119) with videos related to
Sort By:
Page
of 12
BMJ Open
|
July 25, 2018
Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States
Xiaomei Ma, David P Steensma, Bart L Scott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2017
Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents
Moreno Festuccia, Kelsey Baker, Theodore A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 30, 2016
Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial
Janghee Woo, H Joachim Deeg, Barry Storer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
November 17, 2015
The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis
Bethany T Samuelson, Sara K Vesely, Chatree Chai-Adisaksopha, et al.
British Journal of Haematology
|
March 25, 2010
Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study
Bart L Scott, Aravind Ramakrishnan, Mark Fosdal, et al.
Blood
|
July 9, 2008
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome
Bart L Scott, Denise A Wells, Michael R Loken, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 4, 2019
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab
Jason P Cooper, Rafic J Farah, Philip A Stevenson, et al.
British Journal of Haematology
|
January 13, 2010
Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept
Bart L Scott, Aravind Ramakrishnan, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 24, 2007
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia
Bart L Scott, Barry E Storer, Joanne E Greene, et al.
Bone Marrow Transplantation
|
September 2, 2018
Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD
Armin Rashidi, Ryan Shanley, Claudio Anasetti, et al.
Page
of 12